Researcher's suit against NCI wins mixed judgment.

J. Fox

DOI: https://doi.org/10.1126/science.6484568

IF: 56.9

1984-10-12

Science

Abstract:

What problem does this paper attempt to address?

Human Monkeypox: A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies

Diana Emilia Martínez-Fernández,David Fernández-Quezada,Fidel Antonio Guadalupe Casillas-Muñoz,Francisco Josué Carrillo-Ballesteros,Ana Maria Ortega-Prieto,Jose M. Jimenez-Guardeño,Jose Angel Regla-Nava

DOI: https://doi.org/10.3390/pathogens12070947

IF: 3.7

2023-07-19

Pathogens

Abstract:Monkeypox virus (MPXV) is an emerging zoonotic virus that belongs to the Orthopoxvirus genus and presents clinical symptoms similar to those of smallpox, such as fever and vesicular–pustular skin lesions. However, the differential diagnosis between smallpox and monkeypox is that smallpox does not cause lymphadenopathy but monkeypox generates swelling in the lymph nodes. Since the eradication of smallpox, MPXV has been identified as the most common Orthopoxvirus to cause human disease. Despite MPXV being endemic to certain regions of Africa, the current MPXV outbreak, which began in early 2022, has spread to numerous countries worldwide, raising global concern. As of the end of May 2023, over 87,545 cases and 141 deaths have been reported, with most cases identified in non-endemic countries, primarily due to human-to-human transmission. To better understand this emerging threat, this review presents an overview of key aspects of MPXV infection, including its animal reservoirs, modes of transmission, animal models, epidemiology, clinical and immunological features, diagnosis, treatments, vaccines, and prevention strategies. The material presented here provides a comprehensive understanding of MPXV as a disease, while emphasizing the significance and unique characteristics of the 2022 outbreak. This offers valuable information that can inform future research and aid in the development of effective interventions.

microbiology
Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis

Aysel Karagoz,Huseyin Tombuloglu,Moneerah Alsaeed,Guzin Tombuloglu,Abdullah A AlRubaish,Amal Mahmoud,Samira Smajlović,Sabahudin Ćordić,Ali A Rabaan,Ebtesam Alsuhaimi

DOI: https://doi.org/10.1016/j.jiph.2023.02.003

Abstract:Monkeypox virus (MPXV) is a double-stranded DNA virus belonging to the Poxviridae family of the genus Orthopoxvirus with two different clades known as West African and Congo Basin. Monkeypox (MPX) is a zoonosis that arises from the MPXV and causes a smallpox-like disease. The endemic disease status of MPX was updated to an outbreak worldwide in 2022. Thus, the condition was declared a global health emergency independent of travel issues, accounting for the primary reason for its prevalence outside Africa. In addition to identified transmission mediators through animal-to-human and human-to-human, especially sexual transmission among men who have sex with men came to prominence in the 2022 global outbreak. Although the severity and prevalence of the disease differ depending on age and gender, some symptoms are commonly observed. Clinical signs such as fever, muscle and headache pain, swollen lymph nodes, and skin rashes in defined body regions are standard and an indicator for the first step of diagnosis. By following the clinical signs, laboratory diagnostic tests like conventional polymerase chain reaction (PCR) or real-time PCR (RT-PCR) are the most common and accurate diagnostic methods. Antiviral drugs such as tecovirimat, cidofovir, and brincidofovir are used for symptomatic treatment. There is no MPXV-specific vaccine; however, currently available vaccines against smallpox enhance the immunization rate. This comprehensive review covers the MPX disease history and the current state of knowledge by assessing broad topics and views related to disease origin, transmission, epidemiology, severity, genome organization and evolution, diagnosis, treatment, and prevention.
Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments

Liyan Niu,Dingfa Liang,Qin Ling,Jing Zhang,Ziwen Li,Deju Zhang,Panpan Xia,Zicheng Zhu,Jitao Lin,Ao Shi,Jianyong Ma,Peng Yu,Xiao Liu

DOI: https://doi.org/10.3389/fimmu.2023.1132250

IF: 7.3

2023-03-22

Frontiers in Immunology

Abstract:On 23rd July 2022, the World Health Organization (WHO) recognized the ongoing monkeypox outbreak as a public medical crisis. Monkeypox virus (MPV), the etiological agent of monkeypox, is a zoonotic, linear, double-stranded DNA virus. In 1970, the Democratic Republic of the Congo reported the first case of MPV infection. Human-to-human transmission can happen through sexual contact, inhaled droplets, or skin-to-skin contact. Once inoculated, the viruses multiply rapidly and spread into the bloodstream to cause viremia, which then affect multiple organs, including the skin, gastrointestinal tract, genitals, lungs, and liver. By September 9, 2022, more than 57,000 cases had been reported in 103 locations, especially in Europe and the United States. Infected patients are characterized by physical symptoms such as red rash, fatigue, backache, muscle aches, headache, and fever. A variety of medical strategies are available for orthopoxviruses, including monkeypox. Monkeypox prevention following the smallpox vaccine has shown up to 85% efficacy, and several antiviral drugs, such as Cidofovir and Brincidofovir, may slow the viral spread. In this article, we review the origin, pathophysiology, global epidemiology, clinical manifestation, and possible treatments of MPV to prevent the propagation of the virus and provide cues to generate specific drugs.

immunology
Research progress of Monkeypox and its current prevention and treatment options

Xinmei Zheng

DOI: https://doi.org/10.54254/2753-8818/22/20230983

2023-12-20

Abstract:Monkeypox (MPX), a smallpox-like zoonotic infectious disease caused by the monkeypox virus (MPXV), was first detected in laboratory animals in 1958. Since the eradication of the smallpox virus in the 80s of the 20th century, MPXV has become one of the members of the pox virus family with the greatest public health impact, mainly in the central and western regions of Africa. However, since May 7, 2022, human cases of MPXV infection have been reported in several countries outside endemic areas in Africa. As of July 15, 2022, based on the latest data from the US Centers for Disease Control and Prevention, there have been at least 1,814 suspected or confirmed cases in the US, and a total of 12,556 confirmed cases have been reported in 68 countries around the world. The World Health Organization (WHO) has said that the spread of MPX epidemics in more than 70 countries is an "extraordinary" situation, listing it as a global emergency. This paper mainly reviews the physicochemical characteristics, gene characteristics, pathogenic mechanism, transmission mechanism, and clinical features of MPXV etiology. It also discusses and summarizes the current prevention and treatment options, in order to provide reference for the current exploration of monkeypox prevention and treatment.
Monkeypox virus: insights into pathogenesis and laboratory testing methods

Anoop Kumar,Neeraj Singh,Anupkumar R. Anvikar,Gauri Misra

DOI: https://doi.org/10.1007/s13205-024-03920-z

IF: 2.893

2024-02-13

3 Biotech

Abstract:The monkeypox virus (MPXV) is a zoonotic pathogen that transmits between monkeys and humans, exhibiting clinical similarities with the smallpox virus. Studies on the immunopathogenesis of MPXV revealed that an initial strong innate immune response is elicited on viral infection that subsequently helps in circumventing the host defense. Once the World Health Organization (WHO) declared it a global public health emergency in July 2022, it became essential to clearly demarcate the MPXV-induced symptoms from other viral infections. We have exhaustively searched the various databases involving Google Scholar, PubMed, and Medline to extract the information comprehensively compiled in this review. The primary focus of this review is to describe the diagnostic methods for MPXV such as polymerase chain reaction (PCR), and serological assays, along with developments in viral isolation, imaging techniques, and next-generation sequencing. These innovative technologies have the potential to greatly enhance the accuracy of diagnostic procedures. Significant discoveries involving MPXV immunopathogenesis have also been highlighted. Overall, this will be a knowledge repertoire that will be crucial for the development of efficient monitoring and control strategies in response to the MPXV infection helping clinicians and researchers in formulating healthcare strategies.

biotechnology & applied microbiology
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-emerging Human Monkeypox Virus

Wooseong Lee,Yu-Jin Kim,Su Jin Lee,Dae-Gyun Ahn,Seong-Jun Kim

DOI: https://doi.org/10.4014/jmb.2306.06033

2023-07-25

Journal of Microbiology and Biotechnology

Abstract:Monkeypox (Mpox) virus, a member of the <i>Poxviridae</i> family, causes a severe illness similar to smallpox, which is characterized by symptoms such as high fever, rash, and pustules. Human-to-human transmission cases have been reported but remained low since the first recorded case of human infection occurred in the Congo in 1970. Recently, Mpox has re-emerged, leading to an alarming surge in infections worldwide since 2022, originating in the United Kingdom. Consequently, the World Health Organization (WHO) officially declared the '2022-23 Mpox outbreak'. Currently, no specific therapy or vaccine is available for Mpox. Therefore, patients infected with Mpox are treated using conventional therapies developed for smallpox. However, the vaccines developed for smallpox have demonstrated only partial efficacy against Mpox, allowing viral transmission among humans. In this review, we discuss the current epidemiology of the ongoing Mpox outbreak and provide an update on the progress made in diagnosis, treatment, and development of vaccines for Mpox.

biotechnology & applied microbiology,microbiology
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review

Boghuma K Titanji,Aniruddha Hazra,Jason Zucker

DOI: https://doi.org/10.1001/jama.2024.21091

IF: 11.816

2024-11-19

JAMA

Abstract:Importance: A global outbreak of clade IIb Monkeypox virus (MPXV) infections spread rapidly across at least 118 countries resulting in a Public Health Emergency of International Concern (PHEIC) from July 2022 to May 2023. This outbreak affected more than 99 000 persons worldwide and caused more than 33 000 infections and 60 deaths in the US. In 2024, there have been approximately 200 new infections per month in the US. On August 14, 2024, the World Health Organization declared mpox a PHEIC for a second time due to a rapid increase in infections with clade I MPXV in Central Africa. Observations: Mpox is primarily acquired through direct skin to skin contact with MPXV. With clade IIb MPXV, infections are most commonly associated with sexual activity among individuals who are gay, bisexual, and other men who have sex with men. After a median incubation period of 7 to 10 days, prodromal symptoms include fever (62%-72%), lymphadenopathy (56%-86%), myalgias (31%-55%), malaise (23%-57%), and headache (25%-55%). Skin lesions progress through 4 well-defined stages (macules, papules, vesicles, and pustules) over 2 to 4 weeks. Clade IIb MPXV is typically a self-limited illness with a low mortality rate (<0.2% in the US); however, severe illness and death may occur in immunocompromised individuals, especially those with advanced HIV (CD4 count <200 cells/μL). Mpox should be suspected in patients with potential exposure to MPXV who have skin lesions, and the diagnosis is confirmed with polymerase chain reaction testing of lesions. Management is supportive and focuses on skin care and symptom relief with analgesics. While no antiviral treatments are currently approved for mpox by the US Food and Drug Administration, several therapeutics, such as tecovirimat, brincidofovir, and vaccinia immune globulin intravenous, are available through expanded access programs or clinical trials. Vaccination with the 2-dose Modified Vaccinia Ankara-Bavarian Nordic vaccine is recommended for high-incidence populations and has an efficacy of 66% to 86%. Conclusions and relevance: Mpox is a viral infection transmitted primarily through close skin to skin contact that typically causes a self-resolving illness but can result in severe illness and death in immunocompromised individuals. First-line therapy is supportive care, although patients with severe mpox infection may be treated with advanced therapeutics. Mpox vaccination is effective and, if available, should be offered to individuals at risk of exposure to mpox.
2×2 juxtaposed Type Optical Fiber Raman Temperature Sensor

Zhang Lixun,Liu Yongzhi,O. Zhonghua,Dai Zhiyong,Peng Zengshou

DOI: https://doi.org/10.1109/AOE.2006.307365

2006-10-01

Abstract:We report on a 2times2 juxtaposed type optical fiber Raman temperature sensor. Two output ports of the 2times2 couple make coupling of the optical fiber respectively and two optical fiber made fascis will be a item of the sensor optical fiber. On the condition that the quasi-continuous wave inputs, the couple has the nonlinear switch theory; hence the signals received by the detector will take four times of what a single sensor optical fiber does. A new demodulated method for the simultaneous distributed temperature measurement in an optical fiber based on spatially resolving the anti-Stokes signals of the spontaneous Raman back-scattering, the sensitivity of sensor is heightened. We make up the experimental system and achieve 5 km of length, 1 m of distance resolution, accuracy to plusmn0.1degC
[Clinical value of high-resolution magnetic resonance tomography in the staging of tumors of the oral cavity, the pharynx and the larynx].

E. Scholtz,H. Meyer,L. Guhl,I. Arlart

Abstract:In a prospective study 102 patients with malignant tumors of the tongue, oropharynx, hypopharynx, and larynx were staged by means of MRI. Special attention was directed at those tumour extensions that could influence the treatment strategy. The MR findings were correlated with the results of palpation, endoscopy, ultrasound, computerised tomography and histopathological findings. MRI showed a good delineation of pT2 to pT4 tumours. However, visualisation of small tumours in the soft palate, the tonsils, the pyriform sinuses and vocal cords was difficult. In conclusion our results suggest that in addition to endoscopy MRI is a valuable tool for the examination of tumours of tongue, oropharynx, hypopharynx and larynx.
Insights into the Transmission, Host Range, Genomics, Vaccination, and Current Epidemiology of the Monkeypox Virus

Yusha Araf,Jannatul Ferdous Nipa,Sabekun Naher,Sumaiya Tasnim Maliha,Hasanur Rahman,Kazi Ifthi Arafat,Mohammad Raguib Munif,Md Jamal Uddin,Nurejunnati Jeba,Sukumar Saha,Jingbo Zhai,S M Nazmul Hasan,Mengzhou Xue,Md Golzar Hossain,Chunfu Zheng

DOI: https://doi.org/10.1155/2024/8839830

2024-05-28

Abstract:This review delves into the historical context, current epidemiological landscape, genomics, and pathobiology of monkeypox virus (MPXV). Furthermore, it elucidates the present vaccination status and strategies to curb the spread of monkeypox. Monkeypox, caused by the Orthopoxvirus known as MPXV, is a zoonotic ailment. MPXV can be transmitted from person to person through respiratory droplets during prolonged face-to-face interactions. While many cases of monkeypox are self-limiting, vulnerable groups such as young children, pregnant women, and immunocompromised individuals may experience severe manifestations. Diagnosis predominantly relies on clinical presentations, complemented by laboratory techniques like RT-PCR. Although treatment is often not required, severe cases necessitate antiviral medications like tecovirimat, cidofovir, and brincidofovir. Vaccination, particularly using the smallpox vaccine, has proven instrumental in outbreak control, exhibiting an efficacy of at least 85% against mpox as evidenced by data from Africa. Mitigating transmission requires measures like wearing surgical masks, adequately covering skin lesions, and avoiding handling wild animals.
Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease

Sharon Sukhdeo,Sharmistha Mishra,Sharon Walmsley

DOI: https://doi.org/10.1186/s12879-022-07900-7

IF: 3.7

2022-12-13

BMC Infectious Diseases

Abstract:In May 2022, a new global outbreak of mpox (formerly, human monkeypox) emerged that was declared a public health emergency of international concern by the World Health Organization on July 23, 2022. With new patterns of person-to-person spread within sexual networks in nonendemic countries and several differences from the classic disease course, we performed a comprehensive review of existing literature on human monkeypox to discuss epidemiology, modes of transmission, clinical presentation and asymptomatic infection, diagnostics, therapeutics, and vaccines with the primary aim to identify important areas for future research of this new epidemic form of the disease. A comprehensive literature search was performed of all published literature to August 15, 2022. Historically, in regions of monkeypox virus endemicity, human outbreaks have occurred related to discrete zoonotic events. The animal reservoir is unknown, but the virus has been isolated from rodents. Traditionally, transmission occurred by direct or indirect contact with an infected animal. In nonendemic countries affected in the 2022 outbreak, almost exclusive person-to-person spread has been observed, and most cases are connected to sexual networks of gay, bisexual, and other men who have sex with men. After an incubation period of approximately 13 days, in traditional human cases affected persons developed a febrile prodrome preceding a rash that started on the face and body, spread centrifugally to the palms and soles and healed monomorphically over two to four weeks. However, in the 2022 outbreak, the febrile illness is often absent or occurs after the onset of the rash. The rash presents primarily in the anogenital region and face before disseminating throughout the body, with lesions displaying regional pleomorphism. There is a paucity of data for the role of antiviral agents or vaccines. The epidemiology and clinical course of mpox has changed in the 2022 epidemic from that observed with the endemic disease. There is an urgent need to establish rapid and collaborative research platforms to diagnose, treat and prevent disease and inform important public health and other strategies to stop the spread of disease.

infectious diseases
The Changing Global Epidemiology of Re-emerging Human Monkeypox Virus Infection: A Systematic Review

Sunder Sham,Fnu Sapna,Fnu Anjali,Sanjay Kumar,Vivek Podder,Soumya Jaladi,Ahmed Bendari,Reham Al-Refai,Manal M Baloch,Mohammed Abdelwahed,Nfn Kiran,Saroja Devi Geetha,Hansini Laharwani

DOI: https://doi.org/10.7759/cureus.45123

2023-09-12

Cureus

Abstract:Human monkeypox virus (MPVX) infection represents an emerging zoonotic disease caused by an orthopoxvirus, resulting in a condition reminiscent of smallpox. More recent developments have witnessed a notable surge in global MPVX outbreaks, eliciting significant concerns. We aimed to investigate the epidemiological factors of the emerging human monkeypox virus infection, including the number of suspected, confirmed, and fatal cases, as well as the risk factors for contracting monkeypox infection. We performed a systematic review of peer-reviewed literature by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. An electronic database search (PubMed, Wiley Online Library, and Science Direct) was undertaken. For monkeypox-related studies, we included 25 peer-reviewed articles from 2018 and 2022, and data were extracted on the current evidence on the cases and the risk factors for MPVX infection, to develop public health advisories. Our reports show a rapid rise of MPVX cases in the highly endemic African regions after the 1970s, spread to other countries, and an increase in the median age from young children to young adults. The cessation of smallpox vaccination might have been one of the factors responsible for these findings. As of 2022, the genomic sequences of ten MPVX strains associated with the recent countrywide outbreak have been determined. While the West African Clade has been primarily implicated in the recent viral surge, data were insufficient to determine which mutation contributed to increased transmissibility. In the Democratic Republic of the Congo (DRC), sleeping on the floor was significantly associated with contracting MPVX, while eating or processing of animal foods was not a significant risk factor. In the United States, cleaning the cages and bedding of sick animals, touching infected animals, and daily exposure to sick animals were associated with an increased probability of contracting the MPVX infection. Recent global outbreaks and the rising incidence of MPVX infections among young adults in the endemic zones might be a result of the cessation of the smallpox vaccine. The increased risk associated with exposure to sick animals or sleeping on the floor suggests high infectivity from animal excretions. Increasing awareness, strict surveillance, and contact tracing can help contain global outbreaks. The ring vaccination approach for exposed individuals is another potential disease containment strategy. Future studies should investigate measures for rapid laboratory diagnosis, maintaining lab safety, and transmissibility.
A comprehensive review of monkeypox virus and mpox characteristics

Emmanuel Alakunle,Daniel Kolawole,Diana Diaz-Cánova,Faith Alele,Oyelola Adegboye,Ugo Moens,Malachy Ifeanyi Okeke

DOI: https://doi.org/10.3389/fcimb.2024.1360586

IF: 6.073

2024-03-06

Frontiers in Cellular and Infection Microbiology

Abstract:Monkeypox virus (MPXV) is the etiological agent of monkeypox (mpox), a zoonotic disease. MPXV is endemic in the forested regions of West and Central Africa, but the virus has recently spread globally, causing outbreaks in multiple non-endemic countries. In this paper, we review the characteristics of the virus, including its ecology, genomics, infection biology, and evolution. We estimate by phylogenomic molecular clock that the B.1 lineage responsible for the 2022 mpox outbreaks has been in circulation since 2016. We interrogate the host-virus interactions that modulate the virus infection biology, signal transduction, pathogenesis, and host immune responses. We highlight the changing pathophysiology and epidemiology of MPXV and summarize recent advances in the prevention and treatment of mpox. In addition, this review identifies knowledge gaps with respect to the virus and the disease, suggests future research directions to address the knowledge gaps, and proposes a One Health approach as an effective strategy to prevent current and future epidemics of mpox.

immunology,microbiology
Diagnostic approaches for monkeypox virus

Guohao Fan,Jiahua Kuang,Shengjie Zhang,Yang Yang,Yingxia Liu,Hongzhou Lu

DOI: https://doi.org/10.1002/ila2.36

2024-01-01

Abstract:AbstractMpox (formerly Monkeypox) is a zoonotic infection caused by Monkeypox virus (MPXV). Since 2022, Mpox epidemics have occurred in many non‐endemic countries and regions, leading the World Health Organization to declare a public health emergency of international concern. With the persistent transmission and evolution of MPXV, symptoms of Mpox have become milder, with some infections being asymptomatic. In addition, MPXV has become more contagious. Therefore, rapid and accurate diagnosis and screening of MPXV is vital to prevent and control MPXV epidemics. Here, we review and summarize the technical details, application scenarios, and the advantages and disadvantages of MPXV‐specific diagnostic methods.
Understanding the pathogenesis, clinical, laboratory diagnosis and treatment of the recent monkeypox virus outbreak

Aneta-Rada Goia,Delia Muntean,Virgil Musta,Alexandra Herlo,Silvana Vulpie,Oana Izmendi,Romanita Jumanca,Monica Licker

DOI: https://doi.org/10.2478/rrlm-2024-0005

2024-01-01

Revista Romana de Medicina de Laborator

Abstract:Abstract Human mpox is a zoonotic disease, caused by the mpox virus (MPXV), that can spread either between animals and humans or humans and humans. In 1970 the first human case of mpox was reported in Zaire, Democratic Republic of the Congo (DRC). Other notable human mpox outbreaks in non-endemic countries were identified in June 2003 in the United States, in July 2021 in Dallas (USA), and the most recent one in May 2022 in Europe in the United Kingdom (UK). During the 2022 outbreak, sexual intercourse was observed to be the most prevalent transmission method, although other means should not be ignored, such as the involvement of respiratory droplets, exposure to surfaces and skin suspected of contamination. In the context of the current mpox outbreak, we consider it important and necessary to correctly identify the virus, use the proper laboratory testing for a correct diagnosis of mpox, understand the means of prophylaxis, and apply the correct treatment, highlighting these facts being the aim of this study.

medicine, research & experimental
Monkeypox: disease epidemiology, host immunity and clinical interventions

Fok-Moon Lum,Anthony Torres-Ruesta,Matthew Z. Tay,Raymond T. P. Lin,David C. Lye,Laurent Rénia,Lisa F. P. Ng

DOI: https://doi.org/10.1038/s41577-022-00775-4

IF: 108.555

2022-09-09

Nature Reviews Immunology

Abstract:Monkeypox virus (MPXV), which causes disease in humans, has for many years been restricted to the African continent, with only a handful of sporadic cases in other parts of the world. However, unprecedented outbreaks of monkeypox in non-endemic regions have recently taken the world by surprise. In less than 4 months, the number of detected MPXV infections has soared to more than 48,000 cases, recording a total of 13 deaths. In this Review, we discuss the clinical, epidemiological and immunological features of MPXV infections. We also highlight important research questions and new opportunities to tackle the ongoing monkeypox outbreak.

immunology
Monkeypox: epidemiology, pathogenesis, treatment and prevention

Yong Huang,Li Mu,Wei Wang

DOI: https://doi.org/10.1038/s41392-022-01215-4

IF: 39.3

2022-11-03

Signal Transduction and Targeted Therapy

Abstract:Monkeypox is a zoonotic disease that was once endemic in west and central Africa caused by monkeypox virus. However, cases recently have been confirmed in many nonendemic countries outside of Africa. WHO declared the ongoing monkeypox outbreak to be a public health emergency of international concern on July 23, 2022, in the context of the COVID-19 pandemic. The rapidly increasing number of confirmed cases could pose a threat to the international community. Here, we review the epidemiology of monkeypox, monkeypox virus reservoirs, novel transmission patterns, mutations and mechanisms of viral infection, clinical characteristics, laboratory diagnosis and treatment measures. In addition, strategies for the prevention, such as vaccination of smallpox vaccine, is also included. Current epidemiological data indicate that high frequency of human-to-human transmission could lead to further outbreaks, especially among men who have sex with men. The development of antiviral drugs and vaccines against monkeypox virus is urgently needed, despite some therapeutic effects of currently used drugs in the clinic. We provide useful information to improve the understanding of monkeypox virus and give guidance for the government and relative agency to prevent and control the further spread of monkeypox virus.

biochemistry & molecular biology,cell biology
Monkeypox (Mpox): Evolution of Transmission and Comprehensive Review

Pankhuri Dudani,Ananya Sharma,Morini S Tammineni,Somesh Gupta

DOI: https://doi.org/10.4103/ijd.ijd_335_23

Abstract:The human monkeypox (mpox) virus is an orthopox virus that can be transmitted to humans. Though the disease has been endemic in Africa, the recent mpox outbreak since May 2022. We attempted to examine differences between the endemic form of mpox and the current outbreak. Review of electronic medical database with relevant keywords. The current outbreak of mpox has disproportionately impacted the gay, bisexual and other men who have sex with men (MSM) community. This is also the first time that widespread semen testing has turned up evidence of mpox viral deoxyribonucleic acid (DNA). Cases in the present outbreak are more likely to affect adults, involve the genitalia, and have no prodrome. Close diagnostic differentials include varicella and hand-foot-mouth disease. The disease is usually self-limiting; though secondary infections, anorectal pain, pharyngitis, ocular lesions and rarely, renal injury and myocarditis may occur. This review focuses primarily on the novel clinical characteristics and emerging sexual transmission route of the mpox virus, which, although unconfirmed, appears extremely likely as the route of spread. Dermatologists have an important role in this health emergency, as early diagnosis can cause a significant reduction in disease transmission.
Understanding the biology of monkeypox virus to prevent future outbreaks

Bernard Moss

DOI: https://doi.org/10.1038/s41564-024-01690-1

IF: 28.3

2024-05-10

Nature Microbiology

Abstract:Historically, monkeypox (mpox) was a zoonotic disease endemic in Africa. However, in 2022, a global outbreak occurred following a substantial increase in cases in Africa, coupled with spread by international travellers to other continents. Between January 2022 and October 2023, about 91,000 confirmed cases from 115 countries were reported, leading the World Health Organization to declare a public health emergency. The basic biology of monkeypox virus (MPXV) can be inferred from other poxviruses, such as vaccinia virus, and confirmed by genome sequencing. Here the biology of MPXV is reviewed, together with a discussion of adaptive changes during MPXV evolution and implications for transmission. Studying MPXV biology is important to inform specific host interactions, to aid in ongoing outbreaks and to predict those in the future.

microbiology
The Human Monkeypox Virus and Host Immunity: Emerging Diagnostic and Therapeutic Challenges

Vijay Singh,Shailendra Dwivedi,Ruchika Agrawal,Sadashiv,Ghizal Fatima,Afroz Abidi

DOI: https://doi.org/10.2174/0118715265309361240806064619

2024-08-16

Abstract:This article explores the Human Monkeypox Virus (MPV), a contagious virus that causes disease in both vertebrates and insects. It originated in Denmark in 1958 and expanded beyond Africa during the 1970s. The virus was initially detected in the United States in 2003 following the hospitalisation of a toddler who had been bitten by a prairie dog. The article examines the identification of the virus, its categorization into two genetic groups with dif-ferent levels of harmfulness, and its genetic changes over time due to specific influences. Additionally, it investigates the immunological reaction to MPXV, encompassing both the innate and adaptive systems. The essay also addresses the diagnostic difficulties presented by MPXV's resemblance to other orthopoxviruses and the progress made in molecular diagnos-tics. The paper analyses different therapeutic interventions, such as tecovirimat, an antiviral medication, and JYNNEOS, a vaccine, in terms of their efficacy, potential drawbacks, and the difficulties encountered in managing outbreaks. The future outlook emphasises the ne-cessity of inventive research methodologies, worldwide monitoring, and individualised med-ical treatments to counteract the dissemination of MPXV and alleviate its consequences on public health.

Researcher's suit against NCI wins mixed judgment.

Human Monkeypox: A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies

Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis

Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments

Research progress of Monkeypox and its current prevention and treatment options

Monkeypox virus: insights into pathogenesis and laboratory testing methods

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-emerging Human Monkeypox Virus

Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review

2×2 juxtaposed Type Optical Fiber Raman Temperature Sensor

[Clinical value of high-resolution magnetic resonance tomography in the staging of tumors of the oral cavity, the pharynx and the larynx].

Insights into the Transmission, Host Range, Genomics, Vaccination, and Current Epidemiology of the Monkeypox Virus

Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease

The Changing Global Epidemiology of Re-emerging Human Monkeypox Virus Infection: A Systematic Review

A comprehensive review of monkeypox virus and mpox characteristics

Diagnostic approaches for monkeypox virus

Understanding the pathogenesis, clinical, laboratory diagnosis and treatment of the recent monkeypox virus outbreak

Monkeypox: disease epidemiology, host immunity and clinical interventions

Monkeypox: epidemiology, pathogenesis, treatment and prevention

Monkeypox (Mpox): Evolution of Transmission and Comprehensive Review

Understanding the biology of monkeypox virus to prevent future outbreaks

The Human Monkeypox Virus and Host Immunity: Emerging Diagnostic and Therapeutic Challenges